Sphingosine-1-Phosphate Restrains Foamy Macrophage Formation and Modulates Inflammation in Multidrug-Resistant Tuberculosis
- 1Amity University, Noida, Uttar Pradesh
Abstract
The high abundance of lipid loaded foamy macrophages in the granulomatous lesions is a key hallmark of advanced pulmonary tuberculosis. These macrophages serve as lipid-rich intracellular hiding niches that provides Mycobacterium tuberculosis (M.tb) survival and persistence during prolonged anti-tubercular treatment. Persistent infection and dysregulated inflammatory responses further complicate disease control, particularly in multidrug-resistant tuberculosis (MDR-TB), highlighting the need for host-directed therapeutic strategies. Our previous preclinical study demonstrated the therapeutic potential of the host sphingolipid sphingosine-1-phosphate (S1P) in reducing the mycobacterial burden in M.tb-infected animals, accompanied by enhanced pulmonary macrophage activation. To explore its translational potential, we investigated whether S1P modulates foamy macrophage formation in CD14 monocyte-derived macrophages from healthy donors and patients with MDR-TB. Notably, macrophages derived from patients with MDR-TB exhibited greater intracellular lipid droplet accumulation than those derived from healthy donors. This phenotype was further characterized by increased nitric oxide production and quantitative RT-PCR analysis of genes associated with immune regulation and lipid metabolism, including APOE, LDLR1, CLEC4E, CLEC7A, GP96, IL4, and IL13, which suggested a Th2-associated immunological bias in foamy macrophages. Collectively, these findings highlight the potential role of host sphingolipids in modulating foamy macrophage phenotypes and associated immunometabolic dysregulation, supporting further investigation of S1P as a host-directed therapeutic strategy against MDR-TB.
Related
- The sphingosine-1-phosphate receptor functional antagonist fingolimod exacerbates neuroinflammation and tau pathology in a mouse model of tauopathy
- Hydroxytyrosol Restrains NLRP3 Inflammasome Activation and Pyroptosis Through the TLR4/NF-κB Pathway to Prevent Mycoplasma gallisepticum-Inflammation
- MALT1 protease inhibition restrains glioblastoma progression by reversing tumor-associated macrophage-dependent immunosuppression in mice
- The orphan receptor IL-17RD is a negative regulator of RIG-I-like receptor-dependent antiviral innate immunity and restrains SARS-CoV-2-induced lung inflammation
- PPARγ brakes cytosolic DNA-induced macrophage inflammation by super-enhancer metabolic reprogramming
BibTeX
@misc{kumar2026sphingosine1phosphate,
title = {{Sphingosine-1-Phosphate Restrains Foamy Macrophage Formation and Modulates Inflammation in Multidrug-Resistant Tuberculosis}},
author = {A. Kumar and N. Sharma and L. K. Singh and V. Hadda and A. K. Singh and H. Prakash},
howpublished = {bioRxiv},
year = {2026},
month = oct,
doi = {10.64898/2026.10.15.759318},
url = {https://www.biorxiv.org/content/10.64898/2026.10.15.759318v1},
note = {CC BY},
}
RIS
TY - UNPB
TI - Sphingosine-1-Phosphate Restrains Foamy Macrophage Formation and Modulates Inflammation in Multidrug-Resistant Tuberculosis
AU - A. Kumar
AU - N. Sharma
AU - L. K. Singh
AU - V. Hadda
AU - A. K. Singh
AU - H. Prakash
PY - 2026
DA - 2026/10/15
PB - bioRxiv
DO - 10.64898/2026.10.15.759318
UR - https://www.biorxiv.org/content/10.64898/2026.10.15.759318v1
AB - The high abundance of lipid loaded foamy macrophages in the granulomatous lesions is a key hallmark of advanced pulmonary tuberculosis. These macrophages serve as lipid-rich intracellular hiding niches that provides Mycobacterium tuberculosis (M.tb) survival and persistence during prolonged anti-tubercular treatment. Persistent infection and dysregulated inflammatory responses further complicate disease control, particularly in multidrug-resistant tuberculosis (MDR-TB), highlighting the need for host-directed therapeutic strategies. Our previous preclinical study demonstrated the therapeutic potential of the host sphingolipid sphingosine-1-phosphate (S1P) in reducing the mycobacterial burden in M.tb-infected animals, accompanied by enhanced pulmonary macrophage activation. To explore its translational potential, we investigated whether S1P modulates foamy macrophage formation in CD14 monocyte-derived macrophages from healthy donors and patients with MDR-TB. Notably, macrophages derived from patients with MDR-TB exhibited greater intracellular lipid droplet accumulation than those derived from healthy donors. This phenotype was further characterized by increased nitric oxide production and quantitative RT-PCR analysis of genes associated with immune regulation and lipid metabolism, including APOE, LDLR1, CLEC4E, CLEC7A, GP96, IL4, and IL13, which suggested a Th2-associated immunological bias in foamy macrophages. Collectively, these findings highlight the potential role of host sphingolipids in modulating foamy macrophage phenotypes and associated immunometabolic dysregulation, supporting further investigation of S1P as a host-directed therapeutic strategy against MDR-TB.
ER -